{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-043654","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-09-22T12:30:39+00:00","discovered_at":"2026-09-22T12:35:01.437625+00:00","generated_at":"2026-09-22T12:35:13.427512+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"bioAffinity presents CyPath Lung data at NAVREF 2026; cites 92% sensitivity in veteran study","bullets":["Two posters presented Sept 27-30, 2026 in Arlington, VA: one on 3 clinical cases, one on FlowPath Lung study.","FlowPath Lung: 2,000-patient longitudinal study in veterans/military, enrolling at 12 VA centers and 2 military hospitals.","CyPath Lung reported 92% sensitivity, 87% specificity, 99% NPV for pulmonary nodules ≤20 mm.","Poster cites 2024 economic analysis projecting hundreds of millions in potential VA screening savings.","Company appears with new distribution partner AvMEDICAL at first joint federal healthcare market engagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-043654","json":"https://secwatch.observer/filing/0001493152-26-043654.json","markdown":"https://secwatch.observer/filing/0001493152-26-043654.md","text":"https://secwatch.observer/filing/0001493152-26-043654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226043654/0001493152-26-043654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226043654/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-22T12:35:13.427512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}